🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s SMTI Holdings & Trades

First Buy
Q1 2026
Duration Held
2 Quarters
Largest Add
Q2 2026
+72,269 Shares
Current Position
112,207 Shares
$2.65 M Value

Cliff Asness's SMTI Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 112,207 shares of Sanara MedTech Inc. (SMTI) worth $2.65 M, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Cliff Asness has initiated a new position in SMTI, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 72,269 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Sanara MedTech (SMTI) Holding Value Over Time

Track share changes against reported price movement

Quarterly Sanara MedTech (SMTI) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +72,269 Add 180.95% 112,207 $23.59
Q1 2026 +39,938 New Buy 39,938 $17.18

Cliff Asness's Sanara MedTech Investment FAQs

Cliff Asness first purchased Sanara MedTech Inc. (SMTI) in Q1 2026, acquiring 39,938 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Sanara MedTech Inc. (SMTI) for 2 quarters since Q1 2026.

Cliff Asness's largest addition to Sanara MedTech Inc. (SMTI) was in Q2 2026, adding 112,207 shares worth $2.65 M.

According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 112,207 shares of Sanara MedTech Inc. (SMTI), valued at approximately $2.65 M.

As of the Q2 2026 filing, Sanara MedTech Inc. (SMTI) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Sanara MedTech Inc. (SMTI) was 112,207 shares, as reported at the end of Q2 2026.